Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$27.97NASDAQ Previous Close - Last Trade as of 4:00PM ET 2/14/20

Today's Change0(0.00%)
Bid (Size)$27.92 (18)
Ask (Size)$28.15 (49)
Day Low / HighN/A - N/A
Volume1.0 M
 

View Biotechnology IndustryPeer Comparison as of 02/14/2020

 

Aimmune Therapeutics Inc ( NASDAQ )

Price: $27.97
Change: -0.33 (1.17%)
Volume: 1.0 M
4:00PM ET 2/14/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Ligand Pharmaceuticals Inc ( NASDAQ )

Price: $97.23
Change: +1.55 (1.62%)
Volume: 274.7 K
4:00PM ET 2/14/2020
 
 

Heron Therapeutics Inc ( NASDAQ )

Price: $21.00
Change: -0.51 (2.37%)
Volume: 539.9 K
4:00PM ET 2/14/2020
 
 

Arvinas Inc ( NASDAQ )

Price: $50.30
Change: -2.37 (4.50%)
Volume: 645.3 K
4:00PM ET 2/14/2020
 

Read more news Recent News

--Analyst Actions: Wedbush Cuts Price Target on Aimmune Therapeutics to $74 From $81, Maintains Outperform Rating
6:33AM ET 2/06/2020 MT Newswires

Price: 30.28, Change: +0.91, Percent Change: +3.10 ...

Sector Update: Health Care Stocks Surge
3:40PM ET 2/05/2020 MT Newswires

Top Health Care Stocks JNJ +1.14% PFE +1.25% ABT +1.53% MRK -3.28% AMGN +4.93% Health care stocks were sharply higher, with the NYSE Health Care Index...

Sector Update: Health Care Sprinting Forward in Wednesday Afternoon Trading
1:59PM ET 2/05/2020 MT Newswires

Top Health Care Stocks JNJ +1.27% PFE +1.74% ABT +1.22% MRK -3.04% AMGN +5.50% Health care stocks were sharply higher, with the NYSE Health Care Index...

Aimmune Therapeutics Says Nestle to Boost Investment by $200 Million
9:52AM ET 2/05/2020 MT Newswires

Aimmune Therapeutics (AIMT) said Wednesday that Nestle Health Science plans to increase its equity investment in the company to $473 million by investing...

View all Commentary and Analysis

Aimmune Proves Its Worth With Latest FDA Approval; Other Candidates Left To Advance
12:40PM ET 2/11/2020 Seeking Alpha

Aimmune's Approval, And Other News: The Good, Bad And Ugly Of Biopharma
10:53PM ET 2/03/2020 Seeking Alpha

Biotechs Feel The Bern
9:30AM ET 2/03/2020 Seeking Alpha

Tech Majors, Boeing, UPS And Tesla On Tap
6:38AM ET 1/25/2020 Seeking Alpha

Company Profile

Business DescriptionAimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. View company web site for more details
Address8000 Marina Boulevard
Brisbane, California 94005-1884
Phone+1.650.614.5220
Number of Employees215
Recent SEC Filing02/14/20205
President, Chief Executive Officer & DirectorJayson Donald Alexander Dallas
Chief Financial OfficerEric Hands Claude Bjerkholt
Chief Medical OfficerDaniel C. Adelman
Senior VP-Corporate Development & StrategyMary M. Rozenman

Company Highlights

Price Open$28.30
Previous Close$28.30
52 Week Range$16.95 - 37.00
Market Capitalization$1.8 B
Shares Outstanding62.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/27/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.87
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-104.54%

Analyst Ratings as of 12/18/2019

Buy
6
Overweight
1
Hold
4
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset